Cyclin-dependent kinase

May 11, 2020

AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients

Aug 22, 2019

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study

Oct 02, 2018

Dealerware Joins CDK Global Partner Program

Apr 23, 2018

1-2-1 Mobile Joins CDK Global Partner Program

Jan 16, 2018

dealerAffinity Joins Rapidly Expanding Partner Program from CDK Global

Nov 27, 2017

World Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics Pipeline Analysis 2017 - Approximately 24 Drug Candidates in Different Stages of Development

Nov 16, 2017

Global Cancer CDK Inhibitors Market & Clinical Pipeline 2017-2022 - $20 Billion Market Opportunity Assessment

Nov 14, 2017

Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics - Pipeline Analysis 2017

Oct 04, 2017

CDK Global and CarGurus Partner to Provide Powerful Marketing Solutions To Dealers

Jun 21, 2017

Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe

Jun 15, 2017

Tolero Pharmaceuticals to Present Supportive Preclinical Data for Investigational CDK Inhibitor Alvocidib at European Hematology Association Annual Meeting